AbbVie buys blockbuster blood cancer drug maker Pharmacyclics for $21bn

Pharmacyclics makes Imbruvica approved for treatment of three different types of blood cancer.



via IBTimes.co.uk : Articles by Jerin Mathew http://ift.tt/1FcuKRl March 05, 2015 at 12:29PM http://ift.tt/eA8V8J